Shanmuga Hospital
add_icon

Shanmuga Hospital

44.05
-1.95
(-4.24%)
Market Cap
59.95 Cr
PE Ratio
14.89
Volume
6,000.00
Day High - Low
45.00 - 44.00
52W High-Low
56.76 - 31.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
59.95 Cr
EPS
4.03
PE Ratio
14.89
PB Ratio
1.58
Book Value
29.16
EBITDA
8.50
Dividend Yield
0.00 %
Sector
Hospitals
Return on Equity
10.60
Debt to Equity
0.29
Forecast For
Actual

Company News

View All News
Caret
positive
Shanmuga Hospital Limited has purchased and commissioned a Litho Evo Laser Machine at its hospital facility to enhance medical infrastructure and strengthen advanced treatment capabilities in urology and minimally invasive procedures.
positive
Shanmuga Hospital Limited filed a statement confirming no deviations in the utilization of IPO proceeds during the half year ended September 30, 2025. The company raised Rs 2,061.72 lakhs through its IPO with allotment date of February 18, 2025. The opening unutilized IPO proceeds of Rs 1,115.50 lakhs as of March 31, 2025 were fully utilized during May 2025 for the purchase and installation of a robotic surgical machine under capital expenditure. The total IPO funds were allocated across capital expenditure (Rs 1,452.50 lakhs), issue expenses (Rs 225.94 lakhs), and general corporate purposes (Rs 383.28 lakhs). The statement was reviewed by the Audit Committee and approved by the Board on November 12, 2025. External auditors PPN and Company certified that there were no deviations in the use of public issue proceeds for the reporting period.
positive
Shanmuga Hospital Limited announced its unaudited financial results for the half-year ended September 30, 2025. The company reported a net profit of ₹201.13 lakhs compared to ₹181.38 lakhs in the previous period and ₹239.29 lakhs in the corresponding period last year. Revenue from operations stood at ₹2,462.07 lakhs. Total expenses were ₹2,201.68 lakhs, with cost of consumption being the largest component at ₹813.05 lakhs, followed by other expenses at ₹828.12 lakhs and employee benefits expense at ₹366.76 lakhs. The company's earnings per share was ₹1.48 for both basic and diluted calculations. The company completed full utilization of its IPO proceeds of ₹2,061.72 lakhs during the reporting period, with ₹1,452.50 lakhs allocated to capital expenditure and ₹383.28 lakhs for general corporate purposes. The Board of Directors approved these results at their meeting held on November 12, 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
7,235.50
#1 1,04,035.39
60.47
#1 21,994.30
14.76
#1 1,505
24.84
51.01
1,037.00
1,00,876.18
74.04
7,184.10
#1 28.65
1,076
#1 74.34
42.08
896.45
67,678.22
66.33
7,849.70
13.25
809
70.27
46.49
1,916.80
39,171.88
47.03
5,575.00
12.29
790
30.03
52.79
599.40
31,056.17
86.36
4,286.70
15.12
337
14.65
39.40
1,144.20
30,755.00
55.70
3,771.40
12.59
481
21.10
40.77
614.25
24,578.53
70.11
3,067.00
21.98
415
-40.35
41.17
485.05
15,350.38
107.44
1,757.00
27.64
110
71.36
37.41
1,266.40
12,861.45
49.99
1,566.90
17.46
244
-4.30
33.16
5,483.85
12,755.46
#1 26.22
599.90
11.69
58
16.17
28.71
Growth Rate
Revenue Growth
10.83 %
Net Income Growth
-19.23 %
Cash Flow Change
-231.94 %
ROE
-65.39 %
ROCE
-60.25 %
EBITDA Margin (Avg.)
-14.55 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
42
40
43
48
0
Expenses
32
32
34
40
0
EBITDA
9
7
9
9
0
Operating Profit %
22 %
19 %
20 %
17 %
0 %
Depreciation
0
1
1
2
0
Interest
0
0
1
1
0
Profit Before Tax
9
7
7
6
0
Tax
2
2
2
2
0
Net Profit
7
5
5
4
0
EPS in ₹
6.91
4.90
5.36
4.03
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
11
23
34
53
Fixed Assets
2
10
16
22
Current Assets
8
13
14
30
Capital Work in Progress
0
0
4
0
Investments
0
0
0
0
Other Assets
8
13
14
30
Total Liabilities
11
23
34
53
Current Liabilities
4
7
13
9
Non Current Liabilities
0
4
4
4
Total Equity
7
12
17
40
Reserve & Surplus
7
12
7
26
Share Capital
0
0
10
14

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
2
-1
-1
Investing Activities
-2
-8
-12
-5
Operating Activities
2
3
10
-13
Financing Activities
0
7
1
16

Share Holding

% Holding
Dec 2024
Feb 2025
Mar 2025
Sept 2025
Promoter
71.95 %
71.95 %
72.11 %
72.06 %
FIIs
0.00 %
0.00 %
0.19 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.92 %
25.92 %
24.48 %
24.76 %
Others
2.13 %
2.13 %
3.22 %
3.19 %
No of Share Holders
1,772
9
1,449
1,156

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 38.10 38.50
19 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
19 Sept 2025 45.65 48.00
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 42.50 42.65

Announcements

Intimation Regarding Commissioning And Operationalisation Of Litho Evo Laser Machine7 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 28, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 28, 2025
Statement On Deviation Or VariationNov 12, 2025
Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Half Year Ended 30Th September 2025 Together With The Limited Review Report.Nov 12, 2025
Board Meeting Intimation for To Approve The Unaudited Financial Results For The Half Year Ended On 30Th September 2025Nov 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 08, 2025
Shanmuga Hospital Limited Honoured At Times Healthcare Achievers - Tamil Nadu 2025 For Contribution To HealthcareSep 30, 2025
Closure Of Shanmuga ClinicsSep 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 25, 2025
Closure of Trading WindowSep 25, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 22, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Intimation Of Book Closure For The Purpose Of 05Th Annual General Meeting Of The Company.Sep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeSep 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Reg. 34 (1) Annual Report.Aug 25, 2025
Notice Of The 05Th Annual General Meeting Of Shanmuga Hospital Limited Is Scheduled To Be Held On Friday The 19Th September 2025 At 03.00 P.M. Through Video Conference Or Other Audio Visual Means.Aug 25, 2025
Intimation Regarding Commissioning And Operationalization Of PH Impedance & Manometry SystemAug 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Intimation Regarding Operationalization Of CT ScannerAug 06, 2025
Board Meeting Intimation for To Fix The Date Of AGMAug 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
CLOSURE OF PHARMACY UNITJun 03, 2025
Statement On Deviation Or VariationMay 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 28, 2025
Audited Financial Results For The Financial Year Ended 31St March 2025.May 28, 2025
Board Meeting Outcome for Approval Of Audited Financial Statements For The Financial Year 2024-25May 28, 2025
Board Meeting Intimation for Approving The Audited Financial Results For The Half Year / Year Ended 31St March 2025.May 21, 2025
Intimation Regarding Operationalization Of Robotic Surgical EquipmentMay 11, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Intimation About Change In CIN Of The CompanyApr 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements Regulations) 2015Mar 31, 2025
Intimation Under Regulation 8(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations) For Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Appointment of Company Secretary and Compliance OfficerMar 31, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 24, 2025

Technical Indicators

RSI(14)
Neutral
48.37
ATR(14)
Less Volatile
2.91
STOCH(9,6)
Neutral
36.68
STOCH RSI(14)
Neutral
49.95
MACD(12,26)
Bearish
-0.31
ADX(14)
Weak Trend
19.79
UO(9)
Bearish
50.46
ROC(12)
Downtrend And Accelerating
-2.44
WillR(14)
Neutral
-73.68